188 related articles for article (PubMed ID: 667828)
1. Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors.
Klubes P; Connelly K; Cerna I; Mandel HG
Cancer Res; 1978 Aug; 38(8):2325-31. PubMed ID: 667828
[No Abstract] [Full Text] [Related]
2. Studies of the antitumor action of 5-fluorouracil (FU).
Mandel HG; Klubes P; Fernandes DJ
Bull Cancer; 1979; 66(1):49-54. PubMed ID: 420946
[No Abstract] [Full Text] [Related]
3. A biochemical and pharmacological study of therapeutic synergism with 5-fluorouracil plus cyclophosphamide in murine L1210 leukemia.
Fernandes DJ; Klubes P
Cancer Res; 1979 Apr; 39(4):1396-404. PubMed ID: 421224
[No Abstract] [Full Text] [Related]
4. Effects of 5-fluorouracil on human colon carcinoma and solid rat Walker 256 carcinosarcoma: evaluation as in vitro predictors of clinical response.
Klubes P; Cerna I; Connelly K; Geelhoed GW; Mandel HG
Cancer Treat Rep; 1978 Jul; 62(7):1065-73. PubMed ID: 688247
[TBL] [Abstract][Full Text] [Related]
5. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
[No Abstract] [Full Text] [Related]
6. Selectivity of action of 5-FU: biochemical basis.
Rustum YM; Danhauser L; Wang G
Bull Cancer; 1979; 66(1):43-7. PubMed ID: 154352
[TBL] [Abstract][Full Text] [Related]
7. Interaction of chemotherapeutic agents with methotrexate and 5-fluorouracil and its effect on de novo DNA synthesis.
Bruckner HW; Schreiber C; Waxman S
Cancer Res; 1975 Mar; 35(3):801-6. PubMed ID: 1116135
[TBL] [Abstract][Full Text] [Related]
8. Increased formation of 5-fluoro-2'-deoxyuridine 5'-monophosphate from 5-fluorouracil in the presence of 2-deoxy-alpha-D-ribose 1-phosphate and 2'-deoxyuridine in Ehrlich ascites tumor cells.
Tamemasa O; Tezuka M
Nucleic Acids Symp Ser; 1980; (8):s169-72. PubMed ID: 7255189
[TBL] [Abstract][Full Text] [Related]
9. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
Sirotnak FM; Donsbach RC
Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
[No Abstract] [Full Text] [Related]
10. The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.
Chadwick M; Rogers WI
Cancer Res; 1972 May; 32(5):1045-56. PubMed ID: 4259631
[No Abstract] [Full Text] [Related]
11. Determinants of response to antimetabolites and their modulation by normal purine and pyrimidine metabolites.
Rustum YM; Danhauser L; Luccioni C; Au JL
Cancer Treat Rep; 1981; 65 Suppl 3():73-82. PubMed ID: 7049369
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
Chabner BA; Chello PL; Bertino JR
Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
[No Abstract] [Full Text] [Related]
13. [Studies in vivo and in vitro on the influence of 5-fluorouracil and n'-(2'-furanidyl)-5-fluorouracil on the walker carcinosarcoma 256 in the rat (author's transl)].
Mattern J; Volm M; Wayss K; Weber N
Arzneimittelforschung; 1980; 30(6):981-4. PubMed ID: 6774738
[TBL] [Abstract][Full Text] [Related]
14. Differential recovery of intestine, bone marrow, and thymus of rats with solid tumors following 5-fluorouracil administration.
Hopkins HA; Kovacs CJ; Looney WB; Wakefield JA
Cancer Biochem Biophys; 1976; 1(6):303-12. PubMed ID: 189899
[TBL] [Abstract][Full Text] [Related]
15. Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil response.
Ardalan B; Buscaglia MD; Schein PS
Biochem Pharmacol; 1978; 27(16):2009-13. PubMed ID: 718724
[No Abstract] [Full Text] [Related]
16. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
Jackman AL; Alison DL; Calvert AH; Harrap KR
Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the incorporation of 5-fluorodeoxyuridylate into DNA of HL-60 cells by metabolic modulations.
Tanaka M; Kimura K; Yoshida S
Cancer Res; 1983 Nov; 43(11):5145-50. PubMed ID: 6225512
[TBL] [Abstract][Full Text] [Related]
18. In vitro effect of sodium warfarin on DNA and RNA synthesis of mouse L1210 leukemic cells and Walker tumor cells.
Chang JC; Hall TC
Oncology; 1973; 28(3):232-7. PubMed ID: 4767109
[No Abstract] [Full Text] [Related]
19. Mechanism for exclusion of 5-fluorouracil from DNA.
Ingraham HA; Tseng BY; Goulian M
Cancer Res; 1980 Apr; 40(4):998-1001. PubMed ID: 6101994
[TBL] [Abstract][Full Text] [Related]
20. Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil.
Washtien WL; Santi DV
Cancer Res; 1979 Sep; 39(9):3397-404. PubMed ID: 157805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
